This expanded indication for Amvuttra makes it the first and only FDA-approved treatment for transthyretin amyloidosis with ...

BRITS have been warned to take extra care when travelling with medication. Many countries, particularly the ones in the EU’s ...

Alnylam Pharmaceuticals' shares rose about 7% before the bell on Friday following U.S. approval for its drug for a rare and deadly heart disease, securing an entry into a market dominated by Pfizer's ...

For months, I've spent my Saturdays speaking with a convicted killer, writes Anne Connolly. He says he's innocent, others ...

Alnylam Pharmaceuticals' shares rose more than 10% on Friday after the drugmaker secured U.S. approval for its heart disease drug, setting the stage for the 23-year-old biotech's next phase of growth.

The Food and Drug Administration (FDA) has approved Arbli™, an oral suspension formulation of losartan potassium.  Arbli, an angiotensin II receptor blocker, is indicated for the treatment of ...

When Patrick Henry spoke that now-infamous line, “Give me liberty or give me death,” he likely intended it as hyperbole, a metaphor, and a call for people to ask themselves what they value. The ...

The Cyclic Olefin Polymer market has witnessed a significant transformation in recent years, driven by the increasing demand for high-performance mat ...